FLUICELL
Fluicell AB is one of the manufacturers of fluid platforms for multifunctional pipettes. Living tissues are composed of a heterogeneous population of individual cells, which can differ dramatically from each other. These differences can have important consequences for the health and propagation of the entire population. To better study disease and aid in drug development, an in-depth analysis of cell behavior and physiological responses can best be accomplished with single-cell data. Our miss... ion is to redefine the approach to cell biology, and drug discovery by providing miniaturized instrumentation for single-cell investigations. The company is a world leader and pioneer in open-volume microfluidics for the life sciences, and holds a strong IP and patent position with five different patent families in the estate. Fluicell counts to their roster some of the world´s most brilliant and influential scientists and innovators in the field. Our devices offer unprecedented data quality, throughput, resolution, and speed at affordable prices together with the capability to generate unique and critical data from single cells.
FLUICELL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
Gothenburg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.fluicell.com
Total Employee:
1+
Status:
Active
Contact:
+46-762-08-33-54
Email Addresses:
[email protected]
Total Funding:
451.46 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Employees Featured
Founder
Stock Details
Investors List
Pensys
Pensys investment in Post-IPO Equity - Fluicell
Johan Stein
Johan Stein investment in Post-IPO Equity - Fluicell
Strategic Wisdom Nordic
Strategic Wisdom Nordic investment in Post-IPO Equity - Fluicell
Almi Invest
Almi Invest investment in Seed Round - Fluicell
Official Site Inspections
http://www.fluicell.com Semrush global rank: 6.77 M Semrush visits lastest month: 801
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Fluicell"
About - Fluicell
Fluicell was founded in 2012, based on a vision to push the boundaries of science. Using our unique single-cell technology, we unlock new ways of studying cells in their native environment. Fluicell's research solutions has made it …See details»
Fluicell
Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte™ platform, based on …See details»
Fluicell - Crunchbase Company Profile & Funding
Fluicell counts to their roster some of the world´s most brilliant and influential scientists and innovators in the field. Our devices offer unprecedented data quality, throughput, resolution, and speed at affordable prices together with the capability to generate unique and …See details»
Investors - Fluicell
Fluicell is an innovation-driven life science company. Our ambition is to redefine how we treat diseases by delivering next-generation regenerative medicine and drug development solutions. The core of Fluicell's product offering is …See details»
Fluicell - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... obfuscated — Oct 16, 2020: Post-IPO Equity - Fluicell . 3: obfuscated. obfuscated. Strategic Wisdom Nordic: Jan 1, 2013: Seed Round - Fluicell . 1: obfuscated. obfuscated. Almi Invest: IPO & Stock Price. Edit IPO & Stock Price Section ...See details»
Fluicell Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Fluicell has 5 employees at their 1 location and kr3.34 m in annual revenue in FY 2023. See insights on Fluicell including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Fluicell - Org Chart, Teams, Culture & Jobs - The Org
View Fluicell's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Fluicell AB Company Description - Stock Analysis
Nov 1, 2024 Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose …See details»
Fluicell - Contacts, Employees, Board Members, Advisors & Alumni
Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes.See details»
Fluicell Company Overview, Contact Details & Competitors | LeadIQ
Based in Gothenburg Sweden, Fluicell is an innovative life science company dedicated to delivering single-cell microfluidic research tools and services for scientists worldwide. The company was founded in 2012 and provides easy-to-use research solutions in 3d single-cell bioprinting of biological tissues as well as single-cell biology and pharmacology.See details»
Fluicell - Products, Competitors, Financials, Employees, …
Fluicell's products are primarily utilized by pharmaceutical companies and academic institutions for drug development and research in diseases such as diabetes and heart disease. It was founded in 2012 and is based in Gothenburg, Sweden. Headquarters Location. Biotech-Huset van 7 Arvid Wallgrens Backe 20.See details»
Management and Board - Fluicell
Gavin is currently the CTO of Fluicell AB and holds a PhD in Chemistry from the University of Washington, Seattle. He was a research assistant at Chalmers University of Technology for 4 years and has published over forty peer-reviewed scientific publications, with a total number of citations of over a thousand. ...See details»
Fluicell AB - Nordic Issuing
Oct 5, 2022 Fluicell AB. Back to all cases. 10 Oct - 24 Oct 2022 Rights issue. Founded in 2012 as a spin-off from Chalmers University of Technology in Sweden, Fluicell is a public biotech company specializing in high resolution bioprinting and single-cell biology. The company is a world leader and pioneer in open-volume microfluidics for the life sciences ...See details»
Fluicell AB (publ) (FLUI.ST) - Yahoo Finance
See the company profile for Fluicell AB (publ) (FLUI.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and ...See details»
Fluicell is Preparing to be the Next Big Player in Sweden's …
Nov 29, 2019 AM Software Markets 2025: Analysis, Data and Forecast. February 27, 2025 Report # AMR-AMSOFT2025-0325See details»
Fluicell - LinkedIn
Fluicell | 3 258 abonnés sur LinkedIn. Making tissue therapeutics possible to defeat serious disease | Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target …See details»
Financial Reports - Fluicell
Fluicell Year-End Report 2017. 2016. Fluicell Annual Report 2016. 2014 - 2015. Fluicell Annual Report 2014-2015. Expertise. We are pioneers in high precision tissue engineering and open volume microfluidics, developing the next generation of products for regenerative medicine and drug screening.See details»
Fluicell will be traded on March 26 after the reverse split 1:350
Mar 20, 2025 Fluicell AB is a Sweden-based company within healthcare industry. It commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Companyâ s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on ...See details»
News and events - Fluicell
Feb 25, 2025 Fluicell initiates in vivo studies in tissue-based type 1 diabetes treatment program. Read more. December 20, 2023. December 20, 2023. Fluicell launches Nexocyte™ platform and unveils new visual identity. Read more. December 4, 2023. February 8, 2024. Researchers create stem cell model to identify potential targeted epilepsy treatment.See details»
Single-cell tools - Fluicell
Fluicell’s ambition is to push the bounds of science for the benefit of human health. Our state-of-the-art microfluidic platforms make it possible to control liquids, measure drug effects and study biology on the level of individual cells. Our single-cell research tools BioPen, Biozone 6 and Dynaflow Resolve adds advanced capabilities across ...See details»